Steward Partners Investment Advisory, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$7,313
-12.1%
4500.0%0.00%
Q1 2024$8,321
-40.9%
4500.0%0.00%
Q4 2023$14,090
+50.2%
4500.0%0.00%
Q3 2023$9,378
-30.9%
450
-20.6%
0.00%
Q2 2023$13,580
+621.6%
567
+467.0%
0.00%
Q1 2023$1,882
+18.2%
1000.0%0.00%
Q4 2022$1,592
-20.4%
1000.0%0.00%
Q3 2022$2,000
+100.0%
1000.0%0.00%
Q2 2022$1,000
-50.0%
1000.0%0.00%
Q1 2022$2,0000.0%1000.0%0.00%
Q4 2021$2,0000.0%1000.0%0.00%
Q3 2021$2,0000.0%1000.0%0.00%
Q2 2021$2,000
-100.0%
100
-99.3%
0.00%
-100.0%
Q1 2021$380,292,000
+4225366.7%
14,740
+8322.9%
0.00%
Q4 2020$9,000
+28.6%
1750.0%0.00%
Q3 2020$7,000
+75.0%
175
+133.3%
0.00%
Q2 2020$4,000
+33.3%
750.0%0.00%
Q1 2020$3,000
-92.9%
75
-95.3%
0.00%
-100.0%
Q2 2019$42,000
-22.2%
1,600
-38.5%
0.00%
-33.3%
Q3 2018$54,000
-48.6%
2,600
-62.3%
0.00%
-50.0%
Q2 2018$105,000
-33.1%
6,900
-1.4%
0.01%
-45.5%
Q1 2018$157,000
-21.5%
7,000
+5.3%
0.01%
-26.7%
Q4 2017$200,0006,6500.02%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 647,833$26,723,00011.32%
GREAT POINT PARTNERS LLC 1,921,563$79,264,0007.13%
Baker Brothers Advisors 41,904,586$1,728,564,0006.91%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 486,000$20,048,0006.47%
Palo Alto Investors LP 1,832,300$75,582,0004.15%
Birchview Capital, LP 204,000$8,416,0002.81%
SECTORAL ASSET MANAGEMENT INC 556,514$22,956,0001.97%
Rock Springs Capital Management LP 1,573,200$64,895,0001.65%
Riggs Asset Managment Co. Inc. 17,470$2,025,0000.85%
PFM Health Sciences, LP 421,087$17,370,0000.80%
View complete list of ACADIA PHARMACEUTICALS INC shareholders